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Abstract 
Exposure to arsenic in individuals has been found to be associated with immune related problems. In earlier stud-
ies, we have demonstrated that amla protects against arsenic induced oxidative stress and apoptosis in thymus and 
spleen of mice. In continuation to that the present study has therefore been focused to investigate the protective effi-
cacy of amla in arsenic induced inflammation and immunotoxicity in mice. The results showed that arsenic treatment 
significantly increased serum urea levels (69 %), glucose levels (48 %) and triglyceride levels (66 %) as compared to 
controls. Mice exposed to arsenic exhibited significant increased in TNF-α (4.3-fold), serum Interleukin-1 beta (three-
fold), Interleukin-6 (3.8-fold) as compared to controls. Arsenic exposure increased the relative frequency of CD8+ (Tc) 
cells sub-population (18.9 %) and decreased CD4+ (Th) cells (2.6 %). Arsenic exposure also significantly decreased 
T (CD3) and B (CD19) cells (21.1 %) as compared to controls. Simultaneously treatment with arsenic and amla sig-
nificantly inhibited serum urea levels (47 %), glucose levels (50 %) and triglyceride levels (14 %). It also significantly 
decreased the TNF-α (1.1-fold), levels of IL-1β (1.6-fold), levels of Interleukin-6 (1.3-fold) in serum as compared to those 
treated with arsenic alone. Simultaneously treatment with arsenic and amla restored the alterations in CD8+ and 
CD4+ cells and also recovered the damages in B and T sub cells population. Results of the present study clearly indi-
cate that arsenic induced immunotoxicity linked with inflammation has been significantly protected through simulta-
neous treatment with arsenic and amla that was due to anti-inflammatory and antioxidant activity of amla.
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Background
Arsenic, a naturally occurring metalloid exists in three 
oxidation states (elemental, trivalent and pentavalent). 
It is widely present in rocks, soil and ground water due 
to geochemical composition and its contamination is 
associated with the global health concern which affects 
millions of people across the worldwide (Rahman et  al. 
2010; Yadav et  al. 2011; Srivastava et  al. 2014). Persons 
from low economic position and malnourishment have 
found to be more vulnerable towards the toxic effect of 
arsenic as such population have mainly depends on the 
available arsenic contaminated water (Sakurai et al. 2005; 
Zablotska et al. 2008). After entering the body, arsenic is 
rapidly undergoes to the metabolic conversion through 
the process of biotransformation where it converts into 
toxic arsenite and then transformed into mon-, di-, and 
trimethylated products (Thomas et  al. 2004; Sakurai 
et  al. 2005). Further, it redistributes itself to the entire 
organ systems of the body and also accumulates in some 
organs (Ratnaike 2003). Exposure of arsenic to individu-
als increased the generation of reactive oxygen species 
and nitric oxide and involved in the production of pro-
inflammatory cytokines (Marnett et al. 2003; Islam et al. 
2007; Palmieri et al. 2007). Elevated levels of interleukin 
6 (IL-6) and tumor necrosis factor alpha (TNFα), pro-
duced by the immune system play an important role in 
increasing the risk of cardiovascular disease. Both IL-6 
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and TNFα involves in the regulation of the synthesis of 
other acute phase proteins which could established risk 
factors for atherosclerosis (Baumann and Gaildie 1994). 
Alterations in both the intracellular and intercellular 
homeostasis of these factors leads to possible cell death, 
inhibition of enzymes, mitochondrial functions and thus 
enhance the induction of several stress genes (Liu et  al. 
2001; Singh et al. 2013; Srivastava et al. 2014).
Arsenic exposure in individuals have been reported to 
cause fetal death due to increased placental inflamma-
tory response, reduced placental T cells and altered lev-
els of cord blood cytokines (Escobar et al. 2010; Ahmed 
et al. 2011). Arsenic exposure in pregnant may increased 
the risk of infectious diseases in both mothers and chil-
dren, indicating arsenic related immunosuppression 
(Moore et al. 2009; Raqib et al. 2009; Rahman et al. 2010). 
Immune related disorders associated with poor devel-
opment of thymus in infants during the pregnancy in 
arsenic exposed population have also been reported in 
epidemiological studies (Andrew et al. 2008; Moore et al. 
2009; Banerjee et  al. 2011). Studies have been reported 
that chronic exposure to arsenic impairs lymphocyte, 
monocyte, and macrophage activity and also affects cel-
lular immune responses in mammals, resulting in immu-
nosuppression (Lemarie et  al. 2006; Sakurai et  al. 2006; 
Selgrade 2007; Burchiel et  al. 2009; Qian et  al. 2010). A 
reduction in CD4+ cell counts, CD4+ :CD8+ cell ratios, 
and T-regulatory cell levels has been reported in adults 
and children following exposure to arsenic (McCollum 
et  al. 2005; Hernandez-Castro et  al. 2009). Susceptibil-
ity of activation of inflammatory cytokines involved in 
immune related disorders have been reported in humans 
and rodents exposed to arsenic (Fry et al. 2007).
In recent years, a number of plant products, their active 
constituents and herbal agents have been used to pro-
tect against arsenic induced toxicity (Sharma et al. 2009; 
Singh et al. 2013, 2014a; Srivastava et al. 2014). The fruit 
extract of Emblica officinalis and its active constituents 
have long been used in Chinese and Indian traditional 
system of medicine and has shown anti-oxidative, anti-
inflammatory, anti-cancer and immunomodulatory prop-
erties (SaiRam et  al. 2002; Sreeramulu and Raghunath, 
2009; Singh et al. 2013, 2014a). Amla is a rich source of 
Vitamin C, a water soluble anti-oxidant, a wide variety of 
phenolics like anthocyanins, flavonols, ellagic acid and 
its derivatives that acts as a scavenger of free radicals 
and plays an important role to protect against lipid dam-
age, protein oxidation and DNA oxidation (Sreeramulu 
and Raghunath 2009; Singh et al. 2013, 2014a). We have 
recently reported that arsenic induced enhanced oxida-
tive stress linked with apoptosis in thymocytes of mice 
has been found to be protected through treatment with 
amla (Singh et al. 2013, 2014a). Arsenic induced hepatic 
toxicity associated with its accumulation in the liver and 
impaired antioxidant status has also been found to be 
protected following simultaneous treatment with arsenic 
and amla (Singh et al. 2014b). The anti-oxidant potential 
of amla and its various constituents have been reported 
but not much is known about its role on inflammatory 
cytokines in arsenic induced toxicity. Present study has 
therefore been carried out to understand the protective 
role of the fruit extract of amla in arsenic induced inflam-
mation and immunotoxicity in mice.
Methods
Animals and treatment
The present study was approved by the institutional ani-
mal ethics committee of King George Medical University, 
Lucknow (No. 121 IAH/Pharma-11), India, and all exper-
iments were carried out in accordance with guidelines set 
by the Committee for the Purpose of Control and Super-
vision of Experiments on Animals (CPCSEA), Ministry 
of Environment and Forests (Government of India), New 
Delhi, India. Male Balb/c mice (15 ± 2 g) were obtained 
from the animal breeding colony of CSIR-Indian Institute 
of Toxicology Research, Lucknow. Mice were housed in 
an air-conditioned room at 25 ± 2  °C with a 12 h light/
dark cycle under standard hygiene conditions and had 
ad  libitum access to a pellet diet and filtered water. The 
dose of fruit extract of Embilica officinalis and arsenic is 
based on our previous findings (Singh et al. 2013, 2014a) 
for the present study. The mice were randomly divided 
into four groups with 10 animals/group and the dose of 
arsenic and amla were given with the help of canola after 
dissolving in suitable solvent:
  • Group I—Mice treated with vehicle (2 % gum acacia) 
for duration of treatment and served as control.
  • Group II—Mice treated with sodium arsenite (dis-
solved in distilled water at 3  mg arsenic/kg body 
weight, per os daily for 30 days).
  • Group III—Mice treated with fruit extract of Emblica 
officinalis (500 mg/kg body weight, suspended in 2 % 
gum acacia, per os daily for 30 days).
  • Group IV—Mice co-treated daily with arsenic and 
fruit extract as in Groups II and III.
Blood/tissues collection
At the end of the experimental period (30  days), a set 
of animals were sacrificed by cervical dislocation. In 
another set, after heart puncher blood was quickly col-
lected in 10 % EDTA tubes for the separation of serum. 
For the assessment of different inflammatory markers, 
the thymus and spleen were isolated from mice follow-
ing the procedure of Pathak and Khandelwal (2009). The 
thymus and spleen of five mice/groups were cleaned and 
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placed in phosphate-buffered saline (PBS, pH 7.4) and 
subsequently processed for measures of immunological 
parameters. The remaining thymus and spleen in each 
set were placed in ice-cold saline solution (0.15 M), blot-
dried, weighed, and then immediately processed for use 
in assessment of arsenic level in both tissues.
Preparation of thymocyte splenocytes suspension
The dissected thymus and spleen from mice and sin-
gle cell suspension were prepared under aseptic condi-
tion. The suspension were passed through stainless steel 
mesh centrifuged at 200×g at 4 °C for 10 min thymocytes 
resuspended in PBS. Splenocytes were suspended in 
5.0 ml hypotonic erythrocyte lysing solution (2.42 g Tris 
and 7.56 g NH4Cl in 1.0 l deionised water, pH adjusted to 
7.2). After 5  min incubation followed by centrifugation, 
cells were resuspended in PBS, counted through a hemo-
cytometer and then diluted with PBS to appropriate con-
centrations for use in immunological assays.
Assay of serum biochemical parameters
Serum samples collected from the blood were sub-
jected to biochemical estimations of serum urea, glucose 
and TG level and the activity of serum were measured 
through fully automated biochemical analyzer (CHEM-
WELL1520, USA). All serum samples were analyzed in 
duplicate and then mean values were taken.
Assay of nitric oxide levels
Levels of nitric oxide in serum were estimated using the 
nitric oxide assay kit procured commercially (Calbio-
chem, USA) following the method of Misko et al. (1993). 
The assay principle involves the conversion of nitrate 
to nitrite by the enzymatic action of nitrate reductase. 
Addition of 2,3-diaminonaphthalene (DAN) and sodium 
hydroxide converts nitrite to a fluorescent compound 
1(H)-naphthotriazole which is measured spectrofluro-
metrically (excitation 430  nm/emission 450  nm) using 
multi well plate reader. The results are expressed as p 
mole nitrate/mg tissue weight.
Cytokine determination
The parameters related with the cytokine determination 
have been carried out following the method of Singh 
et al. (2010a, b).
Assay of serum Interleukin‑1 beta (IL‑1β)
The levels of Interleukin-1 beta in serum of mice exposed 
to arsenic and simultaneous treatment of arsenic and 
amla were estimated by using the Quantikine mouse 
IL-1β kit obtained from R&D systems. This assay employs 
the quantitative sandwich enzyme immunoassay tech-
nique (ELISA). An affinity purified polyclonal antibody 
specific for mouse IL-1β pre-coated plates was used. The 
intensity of the colour measured was in proportion to the 
amount of mouse IL-1β bound to the sample.
Assay of serum Interleukin‑6 (IL‑6)
The levels of Interleukin-6 in serum of mice exposed to 
arsenic and simultaneous treatment of arsenic and amla 
were quantified by using an enzyme linked immunosorb-
ent assay (ELISA) method through the Quantikine mouse 
IL-6 kit obtained from R&D systems. The intensity of 
the colour measured was in proportion to the amount of 
mouse IL-6 bound to the sample. The levels of IL-6 were 
calculated using a standard curve.
Assay of serum tumor necrosis factor‑alpha (TNF‑α)
The quantitative measurements of the level of TNF-α in 
serum of mice were performed by using the solid phase 
ELISA. This assay employs the quantitative sandwich 
enzyme immunoassay technique. The 96-well pre-coated 
plate with polyclonal antibody specific for mouse TNF-α 
was used. The intensity of the colour measured was in 
proportion to the amount of serum TNF-α bound to 
the sample. The levels of TNF-α were calculated using a 
standard curve.
Assessment of T and B lymphocyte population 
in thymocytes and spleenocytes
T-cells phenotyping were conducted on the basis 
of CD4 and CD8 surface molecules. Positioning of 
quadrants on FITC/PE dot plots were performed 
and CD4+CD8+  (double positive; DP) and CD4−
CD8−  (double negative; DN) sub-populations were dis-
tinguished. The lymphocyte population of splenocytes 
were assessed based on CD3 (for T-cells) and CD19 (for 
B-cells) surface molecules. Briefly, cells were suspended 
in 1 ml PBS. An aliquot of 100 µl was incubated with 5 µl 
FITC-conjugated anti-CD4 monoclonal antibody and 
5  µl PE-conjugated anti- CD8 monoclonal antibody for 
thymocytes. On the other hand, splenocytes were incu-
bated with 5  µl FITC-conjugated anti-CD3 monoclonal 
antibody and 5 µl PE conjugated anti-CD19 monoclonal 
antibody separately for 30 min in dark at room temper-
ature. After incubation, 400  µl PBS was added to each 
sample. The FITC and PE fluorescence were measured 
through FL-1 filter (530  nm) and FL-2 filter (585  nm), 
respectively, on flow cytometer and 10,000 events were 
acquired. The data were analysed on Cell Quest software 
and mean fluorescence intensity was obtained by histo-
gram statistics.
Estimation of arsenic levels in thymus and spleen
Arsenic levels in thymus and spleen of mice exposed to 
arsenic and simultaneous treatment of arsenic and amla 
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were estimated by hydride system 60 atomic absorption 
spectrophotometer (HSAAS, ZEEnit 700) following the 
method of Ballentine and Burford (1957). Briefly, 1 ml of 
concentrated nitric acid was added followed by 1  ml of 
perchloric acid to 100 mg of tissue. The sample was then 
digested over a sand bath until the solution became yel-
low in colour. If the colour of the digest was brown, more 
nitric acid and perchloric acid were added and the oxi-
dation was repeated. The digest was made up to known 
volume with deionized water. Aliquots of this were used 
to estimate arsenic using atomic absorption spectropho-
tometer. A calibration curve was constructed by adding 
known amounts of arsenic standard to calculate arsenic 
levels in the thymus and spleen regions.
Statistical analysis
Data were analyzed using one-way analysis of variance 
(ANOVA) followed by a Newman–Keuls test for multi-
ple pair-wise comparisons among the groups. All values 
were expressed as mean (±SEM). P  <  0.05 was consid-
ered significant.
Results
Effect on the levels of nitric oxide
The levels of nitric oxide as a measure of enhanced oxi-
dative stress has been measured and presented in Fig. 1. 
Mice exposed to arsenic exhibited significant increases in 
nitric oxide levels (55 %, p < 0.001) as compared to con-
trols. Simultaneous treatment with arsenic and amla sig-
nificant decreased the nitric oxide levels (20 %, p < 0.05) 
in serum as compared to those treated with arsenic alone. 
No significant effect on nitric oxide levels was observed 
in mice treated with amla alone as compared to controls 
(Fig. 1).
Effect on the serum biochemical level in mice
The effect on the serum biochemical level in mice follow-
ing exposure to arsenic has been represented in Fig.  2. 
The results showed that arsenic treatment significantly 
increased serum urea level (69 %, p < 0.001), glucose level 
(48 %, p < 0.001), triglyceride (TG) level (66 %, p < 0.001) 
compared to the control group. Simultaneously treat-
ment with arsenic and amla significantly inhibited serum 
urea level (47 %, p < 0.001), glucose level (50 %, p < 0.001) 
and TG level (14 %, p < 0.05) as compared to mice treated 
with arsenic alone. No significant effect was observed in 
mice treated with amla alone as compared to controls 
(Fig. 2).
Effect on tumor necrosis factor‑alpha in serum of mice
Effect of arsenic and co-treatment of arsenic and amla on 
TNF-α level in the serum has been presented in Fig.  3. 
Mice exposed to arsenic exhibited significant increases in 
TNF-α (4.3-fold, p < 0.001) as compared to controls. Co-
treatment with arsenic and amla significant decreases the 
TNF-α (1.1-fold, p < 0.05) in serum as compared to those 
treated with arsenic alone. No significant effect on serum 
TNF- α was observed in mice treated with amla alone as 
compared to controls (Fig. 3).
Effect on Interleukin‑1 beta in serum of mice
Figure  4 indicates the effect of arsenic and co-treat-
ment of arsenic and amla on reduced serum level of 
interleukin-1β of mice. Exposure to arsenic in mice 
caused a significantly increases in the levels of serum 
Interleukin-1 beta (threefold, p < 0.001) in mice as com-
pared to controls. Co-treatment with arsenic and amla 
decreases the levels of IL-1β (1.6-fold, p < 0.001) in serum 
of mice as compared to those treated with arsenic alone. 
No significant effect on the levels of Interleukin-1 beta 
was observed in the mice treated with amla alone as 
compared to controls (Fig. 4).
Effect on Interleukin‑6 in serum of mice
Effect of arsenic and co-treatment of arsenic and amla 
on the serum level of Interleukin-6 in mice has been 
presented in Fig.  5. Exposure of arsenic to mice caused 
an increased the serum level of Interleukin-6 (3.8-fold, 
p  <  0.001) as compared to controls. Co-treatment with 
arsenic and amla decreased the serum level of Interleu-
kin-6 (1.3-fold, p  <  0.001) as compared to mice treated 
with arsenic alone suggested the antioxidant activity of 
amla. No significant effect was observed in mice treated 
with amla alone as compared to controls (Fig. 5).
Effect on T and B lymphocyte population in thymocytes 
and spleenocytes of mice
The effect of arsenic on thymocyte and spleenocytes 
population in mice was measured by cell surface marker 
expression using flow cytometry and expressed in 
Fig. 1 Effect of arsenic, amla and their co-treatment on nitrite levels 
of serum of mice. Values are mean ± SEM of five animals in each 
group. a Compared to control group, b compared to arsenic treated 
group. *Significantly differs (p < 0.05)
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Additional file  1: Table S1. Arsenic exposure increased 
the relative frequency of CD8 (Tc) cells sub-population 
from 2.8 to 18.9  % and decreased CD4(Th) cells from 
5.3 to 2.6  % as compared to controls. These distinct 
phenotypic changes were found to be recovered follow-
ing simultaneous treatment with arsenic and amla. Both 
CD8 and CD4 cell types came close to controls i.e. 2.5 
and 3.4  %, respectively as compared to arsenic treated 
group. No significant effect on Th cells and Tc cells ratio 
was observed in mice treated with amla alone as com-
pared to controls group.
Arsenic treated group significantly decreases T (CD3)- 
and B (CD19)-cells from 35.7 to 21.1 % as compared to 
controls. Whereas simultaneously treatment with arsenic 
and amla restored it back to 32.4 %. Similarly, the severely 
affected B cell population was also restored to 50.3  % 
from 32.5 %, by fruit extract of amla. No significant effect 
on the ratio of T/B cells was observed in the mice treated 
with amla alone as compared to controls group.
Effect on arsenic levels in thymus and spleen of mice
A significant increase in the levels of arsenic in thymus 
and spleen (3.5-fold, p  <  0.01), was observed in mice 
exposed to arsenic for 30  days as compared to controls 
(Additional file 1: Table S2). Levels of arsenic were found 
to be significantly decreased in thymus and spleen (1.3-
fold, p < 0.05), in mice simultaneously treated with arse-
nic and amla as compared to mice treated with arsenic 
alone. No significant change in arsenic levels in the thy-
mus and spleen was observed in mice treated with amla 
alone as comparison to controls (Additional file 1: Table 
S2).
Discussion
Clinical and pre-clinical studies showed that arsenic act 
as an immunosuppressant and its exposure in individu-
als caused various immunological disorders at molecular 
and cellular levels (Islam et al. 2007; Biswas et al. 2008). 
Arsenic is a potent immunotoxicant which modulates 
non-specific immune responses and alters the expression 
of cytokines in time and dose dependent manners (Das 
et al. 2011). Enhanced oxidative stress resulting from the 
imbalance between pro- and antioxidant systems leads 
to the disruption of biological membrane and contrib-
utes to inflammation and production of pro- inflamma-
tory cytokines (Chang et al. 2007; Singh et al. 2010a, b). 
Increased generation of free radicals/reactive oxygen 
species (ROS) associated with enhanced oxidative stress 
have been found to be implicated in the induction of 
apoptosis in both patho and physiologic states (Stepnik 
et  al. 2005; Sharma et  al. 2009). Arsenic induced deple-
tion of anti-oxidant defence enzymes including super-
oxide dismutase, catalase, and glutathione peroxidase 
associated with apoptosis, immunotoxicity and hepatic 
damage have been recently reported by us (Singh et  al. 
2013, 2014a, b). In the present study, arsenic treatment 
in mice significantly increased the levels of nitric oxide in 
thymocytes and spleenocytes of mice as compared to the 
controls further indicates the enhanced oxidative stress.
Fig. 2 Effect of arsenic, amla and their co-treatment on biochemical 
estimation in serum of mice. Values are mean ± SEM of five animals 
in each group. a Compared to control group, b compared to arsenic 
treated group. *Significantly differs (p < 0.05)
Fig. 3 Effect of arsenic, amla and their co-treatment on TNF-α in 
serum of mice. Values are mean ± SEM of five animals in each group. 
a Compared to control group, b compared to arsenic treated group. 
*Significantly differs (p < 0.05)
Fig. 4 Effect of arsenic, amla and their co-treatment on IL-1β in 
serum of mice. Values are mean ± SEM of five animals in each group. 
a Compared to control group, b compared to arsenic treated group. 
*Significantly differs (p < 0.05)
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The alterations in the serum urea level considered as a 
significant marker of renal dysfunctions. The increased 
breakdown of tissue, dietary or impaired excretion also 
found to be linked with the high levels of blood urea (Pol-
liack et  al. 1993). The increased urea concentration in 
serum following treatment with arsenic in mice has been 
considered due to its effect on liver functions (Sands 
1999). In human population, chronic arsenic exposure 
has been showed to increase blood glucose level (Tseng 
2004). Enhanced oxidative stress due to arsenic exposure 
damages the β cells of the pancreatic islets leading to 
increase blood glucose levels (Hayden and Tyagi 2002). In 
the present study, arsenic treatment in mice significantly 
increased the serum urea, glucose and triglyceride level 
associated with enhanced levels of nitric oxide clearly 
indicate the increased oxidative burden as compared to 
the controls are consistent with the earlier studies.
In an epidemiological study, Biswas et  al. (2008) 
reported that chronic arsenic exposure through contami-
nated drinking water caused immunosuppression and 
affect the secretion of variety of cytokines in the popu-
lation. Mitochondria are considered as the prime targets 
for arsenic toxicity, these cytokines have been found to be 
involved in the generation of free radicals via mitochon-
drial respiratory chain reaction (Volk et al. 2000). Further, 
the pro-inflammatory cytokines including TNF-α, IL-1β 
and IL-6 are also secrets due to the arsenic toxicity and 
generates inflammatory responses (Duramad et al. 2007; 
Singh et al. 2010a, b; Das et al. 2012). These pro-inflam-
matory mediators are involved in the various biological 
and cellular comebacks including tumor progression, 
growth factor, transcription factor and activation of pro-
apoptotic proteins (Manna et al. 2000). Studies have been 
showed that arsenic exposure increased the incidence of 
autoimmune mediated diseases, increased expression of 
tumor necrosis factor-α (TNFα) and Interleukin-8 (IL-
8) (Bohler et al. 2000; Tseng 2004). Arsenic exposure in 
mammals impairs the activities of lymphocyte, monocyte, 
macrophage and affects the cellular immune responses 
resulting in immunosuppression (Burchiel et  al. 2009; 
Raqib et al. 2009; Qian et al. 2010). In the present study, 
arsenic treatment in mice significantly increased the lev-
els of TNF-α, serum Interleukin-1 beta and Interleukin-6. 
It also increased the relative frequency of CD8+(Tc) cells 
sub-population and decreased CD4+(Th), T (CD3) and B 
(CD19) cells as compared to controls.
Studies have been reported the protective efficacy of 
herbal extracts and synthetic agents in arsenic induced 
oxidative damage and inflammation (Flora and Gupta 
2007; Sharma et al. 2009; Yadav et al. 2009; Singh et al. 
2013, 2014a; Srivastava et  al. 2014). Amla is widely 
accepted as an immune enhancer and have multiple 
pharmacological and immunomodulatory properties 
due to the presence of various phenolics and its deriva-
tives (SaiRam et al. 2002; Sharma et al. 2009; Sreeramulu 
and Raghunath 2009; Singh et  al. 2013). Toxicity pro-
duced through exposure of ethanol, carbon tetrachlo-
ride, or hexachlorocyclohexane have been found to be 
protected following treatment with amla (Pramyothin 
et  al. 2006; Anilkumar et  al. 2007). Oxidative effects of 
arsenic have been found to be counteracted by plant 
extracts and pharmacological agents due to their anti-
oxidant potential and metal binding property (Flora and 
Gupta 2007; Sinha et al. 2008). Amla constitutes vitamin 
C which mainly acts as an antioxidant compound and 
has binding affinity with arsenic. The deficiencies of vita-
min c may cause hyperlipidaemia and liver dysfunctions 
(Sharma et  al. 1989, 1990). Simultaneous exposure of 
antioxidant like vitamins C, E and some essential metal 
such as zinc has been found to be beneficial in increasing 
arsenic mobilization and assisting the recovery of altered 
biochemical levels during chelating therapy (Kannan and 
Flora 2004; Modi et al. 2005). We have recently reported 
the immunomodulatory and anti-oxidative potential of 
amla against arsenic induced oxidative stress and apop-
tosis in thymocytes and spleenocytes of mice (Singh 
et al. 2013, 2014a). In the present study simultaneously 
treatment with arsenic and amla significantly inhibited 
the serum urea, glucose, TG and levels of TNF-α, IL-1β 
and Interleukin-6 in serum. At the same time the arse-
nic induced alterations in CD8+  and CD4+  cells and 
damage in B and T cells population has been found to 
be recovered following simultaneous treatment with 
arsenic and amla as compared to those treated with arse-
nic alone. One of the most interesting observations in 
our study is the ability of amla to reduce the concentra-
tion of arsenic in the thymus and spleen tissue through 
decreased arsenic burden in target tissues by metal 
chelating properties which may play a crucial role in its 
immunoprotective effect.
Fig. 5 Effect of arsenic, amla and their co-treatment on IL-6 in serum 
of mice. Values are mean ± SEM of five animals in each group. a 
Compared to control group, b compared to arsenic treated group. 
*Significantly differs (p < 0.05)
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Conclusions
We can conclude from the present study that arse-
nic induced immunotoxicity linked with inflammation 
has been significantly protected through simultaneous 
treatment with arsenic and amla that was due to anti-
inflammatory and antioxidant activity of amla. The metal 
binding property of amla could reduce the load of arsenic 
in spleen and thymus and help to decrease the generation 
of reactive oxygen and nitrogen species associated with 
the oxidative stress and imparts its protective effects. 
Amla may modulate inflammatory responses by decreas-
ing the production of several chemokines, preventing 
infiltration of immune cells to the damaged area, and pro-
moting the generation of immunoprotective cytokines 
to accelerate the repair process. As the mechanism of 
prevention is not clearly understood, further studies are 
required to investigate the detailed mechanism of immu-
noprotection of amla in arsenic induced immunotoxicity.
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